Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 5, 2008, Pages

  Do Carmo, Jussara M ^a   Hall, John E ^a   Da Silva, Alexandre A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Autonomic nervous system; Diabetes mellitus; Heart rate variability; Streptozotocin

Indexed keywords

ATROPINE; GLUCOSE; LEPTIN; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROPRANOLOL DERIVATIVE; STREPTOZOCIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CHOLINERGIC SYSTEM; CHRONOTROPISM; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ACTIVITY; HEART HEMODYNAMICS; HEART RATE VARIABILITY; HYPERGLYCEMIA; INTRAVENOUS CATHETER; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; TACHYCARDIA; TELEMETRY; VAGUS NERVE STIMULATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BAROREFLEX; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; EATING; HEART; HEART RATE; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, PARENTERAL; LEPTIN; MALE; MUSCARINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VAGUS NERVE;

EID: 57049099914     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00265.2008     Document Type: Article

References (41)

1. Abe H, Minokoski Y, Shimazu T. Effects of beta 3-adrenergic agonist BRL35135A, on glucose uptake in rat skeletal muscle in vitro and in vivo. J Endocrinol 139: 479-486, 1993.
2. Akirav EM, Chan O, Inouye K, Riddell MC, Mathews SG, Vranic M. Partial leptin restoration increases hypothalamic-pituitary adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats. Metabolism 53: 1558-1564, 2004.
3. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 39: 496-501, 2002.
4. Centers for diseases control and prevention (CDC). Prevalence of chronic kidney disease and associated risk factors - United States, 1997-2004. MMWR Morb Mortal Wkly Rep 161: 161-165, 2007.
5. Chang KSK, Lund DD. Alterations in the baroreceptor reflex control of heart rate in streptozotocin diabetic rats. J Mol Cell Cardiol 18: 617-624, 1986.
6. da Silva AA, Tallam LS, Liu J, Hall JE. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. Am J Physiol Regul Integr Comp Physiol 291: R1271-R1282, 2006.
7. da Silva AA, Kuo JJ, Hall JE. Role of hypothalamic melanocortin 3/4 receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension 43: 1312-1317, 2004.
8. D'Amico M, Marfella R, Nappo F, Di Filippo C, De Angelis L, Berrino L, Rossi F, Giugliano D. High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia 44: 464-470, 2001.
9. Dall'Ago P, Silva VOK, De Angelis KDL, Irigoyen MC, Fazan R Jr, Salgado HC. Reflex control of arterial pressure and heart rate in short-term streptozotocin diabetic rats. Braz J Med Biol Res 35: 843-849, 2002.
10. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46: 2040-2043, 1997.
11. Eckberg DL, Harkins SW, Fritsch JM, Musgrave GE, Gardner DF. Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients. J Clin Invest 78: 366-374, 1986.
12. Eto M, Toba K, Akishita M, Kozakik K, Watanabe T, Kim S, Hashimoto M, Sudoh Yoshizumi MN, Ouchi Y. Reduced endothelial vasomotor function and enhanced neointimal formation after vascular injury in a rat of blood pressure variability. Hypertens Res 26: 991-998, 2003.
13. Fazan R Jr, Ballejo G, Salgado MCO, Moraes MFD, Salgado HC. Heart rate variability and baroreceptor function in chronic diabetic rats. Hypertension 30: 632-635, 1997.
14. Fazan VPS, Salgado HC, Barreira AA. Aortic depressor nerve myelinated fibers in acute and chronic experimental diabetes. Am J Hypertens 19: 253-260, 2006.
15. Haque MS, Minokoshi Y, Hamai M, Iwai M, Horiuchi M, Shimazu T. Role of the sympathetic nervous system and insulin enhancing glucose uptake in peripheral tissues after hypothalamic injection of leptin in rats. Diabetes 48: 1706-1712, 1999.
16. Hashimoto M, Harada T, Ishikawa T, Obata M, Shibutani Y. Investigation on diabetic neuropathy assessed by power spectral analysis of heart rate variability in WBN/Kob rats. J Electrocardiol 34: 243-250, 2001.
17. Havel PJ, Sindelar DK, Baskin DG, Dallman MF, Weigle DS, Schwart MW. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 49: 244-252, 2000.
18. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiovascular actions of leptin. Hypertension 30: 619-623, 1997.
19. Hicks KK, Seifen E, Stimers JR, Kennedy RH. Effects of streptozotocin-induced diabetes on heart rate, blood pressure and cardiac autonomic nervous control. J Auton Nerv Syst 69: 21-30, 1998.
20. Hicks KK, Seifen E, Stimers JR, Kennedy RH. Diabetes with and without ketoacidosis on right atrial pacemaker rate and autonomic responsiveness. Am J Physiol Heart Circ Physiol 273: H1888-H1893, 1997.
21. Hilsted J. Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal and metabolic studies. Diabetes 31: 730-737, 1982.
22. Homma S, Yamazaki Y, Karakida T. Blood pressure and heart rate relationship during cervical sympathetic and vagus nerve stimulation in streptozotocin diabetic rats. Brain Res 629: 342-344, 1993.
23. Howarth FC, Jacobson M, Naseer O, Adeghate E. Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Exp Physiol 90: 237-245, 2005.
24. Maeda CY, Fernandes TG, Timm HB, Irigoyen MC. Autonomic dysfunction in short-term experimental diabetes. Hypertension 26: 1100-1104, 1995.
25. Massimini M, Porta A, Mariotti M, Malliani A, Montano N. Heart rate variability is encoded in the spontaneous discharge of thalamic somatosensorial neurons in cat. J Physiol 526: 387-396, 2000.
26. McDowell TS, Chapleau MW, Hajduczok G, Abboud FM. Baroreflex dysfunction in diabetes mellitus. I. Selective impairment of parasympathetic control of heart rate. Am J Physiol Heart Circ Physiol 266: H235-H243, 1994.
27. McDowell TS, Hajduczok G, Abboud FM, Chapleau MW. Baroreflex dysfunction in diabetes mellitus. II. Site of baroreflex impairment in diabetic rabbits. Am J Physiol Heart Circ Physiol 266: H244-H249, 1994.
28. Mesangeau D, Laude D, Elghozi JL. Early detection of cardiovascular autonomic neuropathy in pig using blood pressure and heart rate variability. Cardiovasc Res 45: 889-899, 2000.
29. Minokoshi Y, Haque MS, Shimazu T. Microinjection into the hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 48: 287-291, 1999.
30. Oral EA, Simha V, Ruiz E, Andrewelt A, Premkumar A, Snell P, Wagner AJ, Depaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A. Leptin-replacement therapy for lipodystrophy. N Engl J Med 346: 570-578, 2002.
31. Page MM, Watkins PJ. Cardio-respiratory arrest and diabetic autonomic neuropathy. Lancet 1: 15-16, 1978.
32. Park JY, Chong AY, Cochran EK, Kleiner DE, Haller MJ, Schatz DA, Gorden P. Type 1 diabetes associated with acquire generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. J Clin Endocrinol Metab 93: 26-31, 2008.
33. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci 23: 5998-6004, 2003.
34. Ren J, Gintant GA, Miller RE, Davidoff AJ. High extracellular glucose impairs cardiac E-C coupling in a glycosilation-dependent manner. Am J Physiol Heart Circ Physiol 273: H2876-H2883, 1997.
35. Schwartz MW, Woods SC, Porte D Jr, Seely RJ, Braskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
36. Shaan BD, Maeda CY, Medeiros S, Moraes RS, Ferlin E, Fernandes TG, Ribeiro JP, Schmid H, Irigoyen MC. Time course of changes in heart rate and blood pressure variability in streptozotocin-induced diabetic rats treated with insulin. Braz J Med Biol Res 30: 1081-1086, 1997.
37. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 32: 409-414, 1998.
38. Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401: 73-76, 1999.
39. -/- deficient mice. Diabetes 3: 778-783, 2002.
40. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48: 58-64, 2006.
41. Wang JL, Chinookoswong N, Scully S, Qi M, Shi ZQ. Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology 140: 2117-2124, 1999.